GLP-1 cost estimator
As of October 2026, Zepbound and Wegovy cost $25 a month with covered commercial insurance and a savings card, $149 to $449 through the manufacturers’ cash self-pay programs, and $50 for eligible Medicare patients through the GLP-1 Bridge, against list prices of about $1,086 and $1,349. Pick a drug and coverage to see yours.
Estimated monthly cost
as low as $25/mo
Your copay, not the list price
How you'd pay
Insurance + manufacturer savings card
With a commercial plan that covers Zepbound, the manufacturer savings card can drop your copay to as little as $25 a month. Savings card caps savings at $100/month ($300 per 3-month fill), $1,300/year, 13 fills/year; the card expires December 31, 2026. Your actual copay depends on your plan's tier and deductible.
Source: LillyDirect, Lilly pricing information and Zepbound savings terms (October 2026)
This is an estimate, not a quote. Your real out-of-pocket cost depends on your specific plan, deductible, pharmacy, and eligibility for manufacturer programs — confirm current prices on the manufacturer’s site before deciding.
How the cost actually breaks down
For the FDA-approved obesity GLP-1s, the price you pay is decided less by the drug than by your coverage path. A commercial plan that covers the drug, paired with the manufacturer’s savings card, produces the lowest number — often around $25/month. If your plan excludes weight-loss drugs, that same savings card routes you to a cash self-pay price instead. Paying fully out of pocket uses the same manufacturer self-pay program. Medicare or Medicaid can’t legally use savings cards at all; Medicare’s temporary GLP-1 Bridge charges eligible patients $50 a month through December 2027, and outside it that path is the most expensive and variable. We scope this estimator to Zepbound and Wegovy specifically so every figure stays traceable to a published source; for the diabetes-branded products and the full coverage picture, see our cost and insurance explainer.
Drugs in this estimator
- Zepbound (tirzepatide) — list $1,086/mo
- Wegovy (injection pen) (semaglutide) — list $1,349/mo
- Wegovy (oral pill) (oral semaglutide) — list $1,349/mo
Common questions
- How much does Zepbound cost per month?
- Zepbound's list price is about $1,086 a month, but almost no one pays that. With commercial insurance that covers it, the manufacturer savings card can bring the copay to as little as $25/month. Paying cash, Lilly's self-pay vials or KwikPen run $299–$449/month depending on dose, if you refill within 45 days. On Medicare, eligible patients can get the KwikPen for $50/month through the Medicare GLP-1 Bridge (as of October 2026).
- How much does Wegovy cost per month?
- Wegovy's list price is about $1,349/month. With a covered commercial plan, the savings offer can cut the copay to as little as $25. Paying cash through NovoCare, the pen is $199/month for the first two months then $349 (the HD 7.2 mg pen is $399), and the oral pill is $149–$299/month by dose. Government insurance excludes the savings offer, but eligible Medicare patients pay $50/month through the Medicare GLP-1 Bridge (as of October 2026).
- Why is the price so different depending on insurance?
- GLP-1 weight-loss drugs have a high list price but several discount channels. A commercial plan that covers the drug plus a manufacturer savings card produces the lowest cost (~$25). If your plan doesn't cover it, the savings card routes you to a cash self-pay price instead. Medicare and Medicaid can't legally use manufacturer savings cards; Medicare's temporary GLP-1 Bridge sets a $50 price for eligible patients, but outside it that scenario has the widest range, sometimes close to full list price.
- Are these prices a guaranteed quote?
- No. This is an estimator built from each manufacturer's published list, self-pay, and savings-program prices (Lilly and Novo Nordisk, accessed October 2026). Your actual out-of-pocket cost depends on your specific plan, deductible, pharmacy, and eligibility. Always confirm current pricing on the manufacturer's site.